Physicochemical and biological similarity assessment of LBAL, a biosimilar to adalimumab reference product (Humira®)

LBAL was developed as an adalimumab (Humira®) biosimilar using Chinese hamster ovary cell lines. Comparable quality, safety, and efficacy between a biosimilar and its reference product should be ensured for regulatory approval. Here, we present the results of a comprehensive physicochemical and biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Joon-Cheol, Kwon, O Hwan, Jeong, Rae Ung, Kim, Nayoun, Song, Seonah, Choi, Ilsub, Lee, Juneok, Horiuchi, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Signaling & Biomolecules
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253209/
https://www.ncbi.nlm.nih.gov/pubmed/34262661
http://dx.doi.org/10.1080/19768354.2021.1943709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253209/
https://www.ncbi.nlm.nih.gov/pubmed/34262661
http://dx.doi.org/10.1080/19768354.2021.1943709

Ejemplares similares